What does Evaxion A/S do?

Evaxion A/S is a public company in the Biological Products, (No Diagnostic Substances) industry, incorporated in G7. It is registered with the SEC under CIK 0001828253 and trades on NASDAQ under the ticker EVAX.

How many SEC filings has Evaxion A/S made?

Evaxion A/S has filed 331 documents with the SEC since 2020. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Evaxion A/S

EVAX NASDAQ CIK: 0001828253 Biological Products, (No Diagnostic Substances) Inc. in G7

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 331 filings →

Form	Description	Date
3/A	OWNERSHIP DOCUMENT	Mar 27, 2026
3/A	OWNERSHIP DOCUMENT	Mar 27, 2026
3/A	OWNERSHIP DOCUMENT	Mar 27, 2026
6-K	FORM 6-K	Mar 19, 2026
6-K	FORM 6-K	Mar 19, 2026
3	OWNERSHIP DOCUMENT	Mar 18, 2026
3	OWNERSHIP DOCUMENT	Mar 18, 2026
3	OWNERSHIP DOCUMENT	Mar 18, 2026
3	OWNERSHIP DOCUMENT	Mar 18, 2026
3	OWNERSHIP DOCUMENT	Mar 18, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Evaxion A/S. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001828253
Ticker: EVAX
Exchange: NASDAQ
Incorporated: G7
First Filing: 2020
Total Filings: 331

Biological Products, (No Diagnostic Substances) rankings →